Eukaryotic initiation factor-2B (EIF2B) is a GTP exchange protein essential for protein synthesis. It consists of Alpha (EIF2B1; MIM 606686), beta (EIF2B2), gamma (EIF2B3; MIM 606273), delta (EIF2B4; MIM 606687), and epsilon (EIF2B5; MIM 603945) subunits. EIF2B activates its EIF2 (see MIM 603907) substrate by exchanging EIF2-bound GDP for GTP.[6]
^Anthony TG, Fabian JR, Kimball SR, Jefferson LS (June 2000). "Identification of domains within the epsilon-subunit of the translation initiation factor eIF2B that are necessary for guanine nucleotide exchange activity and eIF2B holoprotein formation".Biochim. Biophys. Acta.1492(1): 56–62.doi:10.1016/S0167-4781(00)00062-2.PMID10858531.
Labauge P, Fogli A, Niel F, Rodriguez D, Boespflug-Tanguy O (2007). "[CACH/VWM syndrome and leucodystrophies related to EIF2B mutations]".Rev. Neurol. (Paris).163(8–9): 793–9.doi:10.1016/s0035-3787(07)91461-7.PMID17878805.
Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HA, Haines JL, Perkicak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995). "Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease".Nature.375(6534): 754–760.Bibcode:1995Natur.375..754S.doi:10.1038/375754a0.PMID7596406.S2CID4308372.
Andersson B, Wentland MA, Ricafrente JY, Liu W, Gibbs RA (1996). "A" double adaptor "method for improved shotgun library construction".Anal. Biochem.236(1): 107–113.doi:10.1006/abio.1996.0138.PMID8619474.
Anthony TG, Fabian JR, Kimball SR, Jefferson LS (2000). "Identification of domains within the epsilon-subunit of the translation initiation factor eIF2B that are necessary for guanine nucleotide exchange activity and eIF2B holoprotein formation".Biochim. Biophys. Acta.1492(1): 56–62.doi:10.1016/S0167-4781(00)00062-2.PMID10858531.
Leegwater PA, Vermeulen G, Könst AA, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach D, Fonds D, van Berkel CG, Lemmers RJ, Frants RR, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS (2001). "Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter".Nat. Genet.29(4): 383–388.doi:10.1038/ng764.PMID11704758.S2CID20313523.
Fogli A, Dionisi-Vici C, Deodato F, Bartuli A, Boespflug-Tanguy O, Bertini E (2003). "A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation".Neurology.59(12): 1966–8.doi:10.1212/01.wnl.0000041666.76863.47.PMID12499492.S2CID13129517.